Related Experiment Video
Updated: Jun 6, 2026

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
Point mutations in c-Myc uncouple neoplastic transformation from multiple other phenotypes in rat fibroblasts
J Anthony Graves1, Kristi Rothermund, Tao Wang
1Division of Hematology/Oncology, Department of Pediatrics, Children's Hospital of Pittsburgh of The University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America. gravja@chp.edu
Abstract:
Deregulation of c-Myc (Myc) occurs in many cancers. In addition to transforming various cell types, Myc also influences additional transformation-associated cellular phenotypes including proliferation, survival, genomic instability, reactive oxygen species production, and metabolism. Although Myc is wild type in most cancers (wtMyc), it occasionally acquires point mutations in certain lymphomas. Some of these mutations confer a survival advantage despite partially attenuating proliferation and transformation. Here, we have evaluated four naturally-occurring or synthetic point mutations of Myc for their ability to affect these phenotypes, as well as to promote genomic instability, to generate reactive oxygen species and to up-regulate aerobic glycolysis and oxidative phosphorylation. Our findings indicate that many of these phenotypes are genetically and functionally independent of one another and are not necessary for transformation. Specifically, the higher rate of glucose metabolism known to be associated with wtMyc deregulation was found to be independent of transformation. One mutation (Q131R) was greatly impaired for nearly all of the studied Myc phenotypes, yet was able to retain some ability to transform. These findings indicate that, while the Myc phenotypes examined here make additive contributions to transformation, none, with the possible exception of increased reliance on extracellular glutamine for survival, are necessary for achieving this state.
Insights
Cancer-driving c-Myc (Myc) mutations can alter cell phenotypes. This study shows that while Myc phenotypes contribute to cancer, they are not all essential for transformation, with some mutations retaining transforming ability.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Deregulation of c-Myc (Myc) is common in cancers and influences phenotypes like proliferation, survival, and metabolism.
- While most cancers have wild-type Myc (wtMyc), some lymphomas feature point mutations that can enhance survival despite reduced proliferation.
Purpose of the Study:
- To evaluate how naturally-occurring or synthetic Myc point mutations affect cancer-associated phenotypes.
- To investigate the impact of these mutations on genomic instability, reactive oxygen species production, and metabolic pathways (aerobic glycolysis and oxidative phosphorylation).
Main Methods:
- Analysis of four naturally-occurring or synthetic Myc point mutations.
- Assessment of Myc's influence on cell proliferation, survival, genomic instability, reactive oxygen species generation, and metabolic activity.
Main Results:
- Many Myc-associated phenotypes are independent and not strictly necessary for transformation.
- Increased glucose metabolism linked to wtMyc deregulation was found to be independent of transformation.
- One mutation (Q131R) showed impaired phenotypes but retained transforming capacity.
Conclusions:
- Myc phenotypes contribute additively to cancer transformation but are not individually essential.
- Except for potential glutamine reliance for survival, other examined Myc phenotypes are not required for transformation.
- Specific Myc mutations can retain transforming ability even with diminished associated phenotypes.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic cells are...
Abnormal Proliferation
Cancers Originate from Somatic Mutations in a Single Cell
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

